Assembly Biosciences, Inc. (ASMB)
34.07
-0.73
(-2.10%)
USD |
NASDAQ |
Aug 28, 16:00
34.00
-0.07
(-0.21%)
After-Hours: 20:00
Assembly Biosciences Debt to Equity Ratio : 0.0077 for June 30, 2026
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.0077 |
| March 31, 2026 | 0.0125 |
| December 31, 2025 | 0.0127 |
| September 30, 2025 | 0.0151 |
| June 30, 2025 | 0.1593 |
| March 31, 2025 | 0.1113 |
| December 31, 2024 | 0.0926 |
| September 30, 2024 | 0.0555 |
| June 30, 2024 | 0.0503 |
| March 31, 2024 | 0.0594 |
| December 31, 2023 | 0.057 |
| September 30, 2023 | 0.022 |
| June 30, 2023 | 0.0321 |
| March 31, 2023 | 0.0373 |
| December 31, 2022 | 0.0419 |
| September 30, 2022 | 0.0419 |
| June 30, 2022 | 0.041 |
| March 31, 2022 | 0.0389 |
| December 31, 2021 | 0.0383 |
| September 30, 2021 | 0.0322 |
| June 30, 2021 | 0.0343 |
| March 31, 2021 | 0.0347 |
| December 31, 2020 | 0.0421 |
| September 30, 2020 | 0.0398 |
| June 30, 2020 | 0.0417 |
| Date | Value |
|---|---|
| March 31, 2020 | 0.0469 |
| December 31, 2019 | 0.0449 |
| September 30, 2019 | 0.0834 |
| June 30, 2019 | 0.0738 |
| March 31, 2019 | 0.0695 |
| December 31, 2018 | 0.00 |
| September 30, 2018 | 0.00 |
| June 30, 2018 | 0.00 |
| March 31, 2018 | 0.00 |
| December 31, 2017 | 0.00 |
| September 30, 2017 | 0.00 |
| June 30, 2017 | 0.00 |
| March 31, 2017 | 0.00 |
| December 31, 2016 | 0.00 |
| September 30, 2016 | 0.00 |
| June 30, 2016 | 0.00 |
| March 31, 2016 | 0.00 |
| December 31, 2015 | 0.00 |
| September 30, 2015 | 0.00 |
| June 30, 2015 | 0.00 |
| March 31, 2015 | 0.00 |
| December 31, 2014 | 0.00 |
| September 30, 2014 | 0.00 |
| June 30, 2014 | 0.00 |
| March 31, 2014 | 0.00 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| Gilead Sciences, Inc. | 2.219 |
| BridgeBio Pharma, Inc. | -1.353 |
| ACADIA Pharmaceuticals, Inc. | 0.0565 |
| Alnylam Pharmaceuticals, Inc. | 2.206 |
| Anika Therapeutics, Inc. | 0.1839 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 330.83M |
| Total Liabilities (Quarterly) | 25.18M |
| Shareholders Equity (Quarterly) | 305.65M |
| Current Ratio | 13.99 |
| Net Debt Paydown Yield | 0.02% |